City
Philadelphia
60 announced deals involving Philadelphia, most recent first, with the firms that advised on each.
Most recent
SEARCH ALL 60 DLA Piper advises Arlington Capital Partners and Everest Clinical Research on acquisition of Firma Clinical Research unit 21 Oct 2026
DLA Piper advises Hyundai Transys Georgia Powertrain on US$560 million expansion 19 Oct 2026
Hogan Lovells Cadwalader advises Ligand on financing agreement with AvenCell Therapeutics 30 Sept 2026
DLA Piper advises Renovo Capital in sale of Otodata to GI Partners 3 Sept 2026
DLA Piper advises Goldman Sachs on its acquisition of LCN Capital Partners 26 Aug 2026
DLA Piper advises Ascensus on its acquisition of AmericanTCS 6 Aug 2026
DLA Piper advises Kira Pharmaceuticals on merger with Jasper Therapeutics 23 Jul 2026
DLA Piper advises Cantor Fitzgerald on Gossamer Bio’s exchange offer and consent solicitation 30 Jun 2026
Hogan Lovells advises Definium Therapeutics, Inc. in Upsized Public Offering 30 Jun 2026
DLA Piper advises Cantor Equity Partners III, Inc. in closing of US$1.7 billion business combination with AIR Limited 5 Jun 2026
DLA Piper advises Chord Music Partners on its US$500 million music royalties backed securitization 4 Jun 2026
DLA Piper advised Cantor Equity Partners III, Inc., a special purpose acquisition company sponsored by an affiliate of Cantor Fitzgerald, in its entry into a business combination agreement with AIR Limited, a global provider of hookah and advanced inhalation technologies. Upon closing, the transaction will result in the combined company, AIR Global Limited, becoming publicly listed in the United States with an enterprise value of US$1.749 billion. The DLA Piper team included Partners Stephen Alicanti and Sidney Burke (both New York), and Associates Carina Meleca (New York), Nick Young (Phoenix), and Luke Postma (Seattle). Additional support was provided by DLA Piper Partners William Bartow, Jae Kim (both Philadelphia), Paolo Morante (New York), Julia Kovacs, Aurelie Ercoli (both Washington, DC), Victoria Richter (Chicago), and Sarah Tauman (San Francisco); Of Counsels Arlette Grabczynska (Chicago), Michael Madigan (New York), and Priya Narahari (Philadelphia); Senior Attorney Brittany Ellenberg (San Francisco); and Associates James Duchesne (Washington, DC), Jianyuan Hua (New York), Bianca LaCaille, Sarah Cooper (both Seattle), Irina Rudenko (Dallas), and Becca Xu (San Diego). With more than 1,000 corporate lawyers globally, DLA Piper helps clients execute complex transactions seamlessly while supporting clients across all stages of development. The firm has been rated number one in global M&A volume for 15 consecutive years, according to Mergermarket, and ranked as number one in VC, PE, and M&A in combined global deal volume, according to PitchBook. DLA Piper enables issuers and underwriters to execute complex securities transactions throughout the world. We offer tactical approaches to financings across equity and debt capital markets, alternative public offerings (de-SPACs, reverse mergers, and direct listings), and other transformative corporate transactions. Lawyers in our Corporate Governance practice act as outside corporate and securities counsel to a wide range of reporting companies by guiding clients through securities offerings and nuanced disclosure, governance, and compliance matters under SEC, Nasdaq, and NYSE rules and regulations. Boards of directors turn to us to navigate complex transactions, special investigations, and challenging risk oversight matters. Please visit Capital Markets and Public Company Advisory and Market Edge. Related professionals:Stephen AlicantiSidney BurkeCarina MelecaNicholas YoungLuke PostmaWilliam BartowJae KimPaolo MoranteJulia KovacsAurélie ErcoliVictoria RichterSarah TaumanArlette GrabczynskaMichael MadiganPriya NarahariJames DuchesneJianyuan HuaBianca LaCailleSarah CooperIrina RudenkoBecca Xu 1 Dec 2025
DLA Piper advises Cantor Equity Partners III, Inc. in business combination with AIR Limited 1 Dec 2025
DLA Piper advises Einride AB on proposed business combination with Legato Merger Corp. III 20 Nov 2025
DLA Piper advises Rely Home on H.I.G. Capital investment 20 Nov 2025
DLA Piper advises the underwriters in Exzeo Group’s US$168 million IPO 20 Nov 2025
DLA Piper advises Renovo Capital in sale of Rochester Sensors to Amphenol 8 Nov 2025
Hogan Lovells advises MindMed in its US$259 million public offering 5 Nov 2025
Hogan Lovells advises Prospector Baseball Group on its launch and acquisition of the Lancaster Stormers baseball team 4 Nov 2025
Hogan Lovells advises EyePoint on its US$150 million follow-on public offering of equity securities 26 Oct 2025
DLA Piper advised Predictive Oncology in US$343.5 million digital asset treasury launch 13 Oct 2025
DLA Piper advises Dentsply Sirona in public offering of US$550 million junior subordinated notes 22 Jul 2025
DLA Piper advises initial purchasers in upsized US$122.5 million convertible notes offering for DeFi Development Corp. 22 Jul 2025
DLA Piper advises COEUS in its sale to Red Nucleus 26 Feb 2025
DLA Piper advises Cuadrilla Capital’s Fund II Closing 14 Feb 2025
DLA Piper advises Underwriters in Butterfly Network’s US$86.9 million Public Offering 12 Feb 2025
Hogan Lovells advises Aquiline in credit investment in S3 Partners 24 Jan 2025
Hogan Lovells advises Republic of Ecuador on historic “debt-for-nature” swap to fund conservation projects in the Ecuadorian Amazon 20 Dec 2024
DLA Piper advises Legrand in its acquisition of Power Bus Way 11 Dec 2024
DLA Piper advises the underwriters on a US$108 million public offering of common stock for Grid Dynamics 21 Nov 2024
Hogan Lovells advises Morgan family in purchasing limited partnership interest in the Philadelphia Phillies 7 Nov 2024
DLA Piper advises Initial Purchasers, led by Cantor Fitzgerald & Co., in $500 Million Convertible Notes Offering for TeraWulf 7 Nov 2024
DLA Piper advises Nemetschek Group on acquisition of GoCanvas Solutions 1 Oct 2024
DLA Piper advises Titan Partners in an underwritten public offering for Owlet, Inc. 18 Sept 2024
DLA Piper advises Cantor Fitzgerald in Zura Bio’s warrant exchange offer and consent solicitation 16 Aug 2024
Hogan Lovells Guides Mind Medicine Inc. on its US$75m Underwritten Public Offering 14 Aug 2024
DLA Piper advises Point72 Private Investments in NaturalCycles US$55 million Series C financing round 7 Aug 2024
Hogan Lovells advises Enstar as it announces agreement to be acquired by Sixth Street for US$5.1 billion 5 Aug 2024
Herbert Smith Freehills advises Aquiline Capital Partners on investment in Isio Topco Limited 10 Jul 2024
Hogan Lovells advises Perspective Therapeutics in its US$80 million underwritten offering of equity securities 4 Jun 2024
Hogan Lovells represents Optinose in its US$55 million registered direct offering 30 May 2024
Hogan Lovells advises Sartorius Group on a cooperation and minority shareholding in TheWell Bioscience Inc. 20 Apr 2024
Ropes & Gray Advises Aquiline in Majority Investment in PharmaForce 18 Jan 2024
Hogan Lovells advises Omega Therapeutics on research collaboration transaction with Novo Nordisk and Flagship Pioneering 12 Jan 2024
Hogan Lovells advises EyePoint Pharmaceuticals on its $230 million follow-on public offering of common stock 9 Dec 2023
DLA Piper advises PRT Growing Services in its acquisition of International Forest Company 29 Apr 2023
DLA Piper advises MetaVC Partners in raising US$62 Million Fund 21 Apr 2023
Hogan Lovells advises Cygna Labs on the acquisition of the VitalQIP product from Nokia 16 Mar 2023
Hogan Lovells guides Kenco Logistics in Pritzker Capital investment 16 Nov 2022
DLA Piper advises T-Mobile in its US$3.5 billion acquisition of spectrum licenses 17 Aug 2022
DLA Piper advises CONMED Corporation in its US$85 million acquisition of Biorez, Inc. 10 Aug 2022
DLA Piper advises Athena Technology Acquisition Corp. in a US$2 billion SPAC deal with Heliogen, Inc. 9 Jul 2021
DLA Piper advises MetaVC Partners in launch of its first venture fund 21 Jun 2021
Hogan Lovells advises NextNav in US$1.2B SPAC merger with Spartacus Acquisition Corporation 11 Jun 2021
Hogan Lovells advises Soliton in US$550 million acquisition by AbbVie’s Allergan Aesthetics 14 May 2021
DLA Piper advises Savant Growth in launch of inaugural private equity fund 18 Feb 2021
Hogan Lovells assists EyePoint Pharmaceuticals on transformative follow-on public offering of common stock 9 Feb 2021
Wells Fargo-led syndicate of lenders successfully negotiate a secured $1.1 billion restructuring credit facility for Pennsylvania Real Estate Investment Trust (PREIT) 16 Dec 2020
DLA Piper advises Open Systems Adaptable Solutions in its acquisition by Aptean 30 Nov 2020
DLA Piper advises CIRCOR in sale of Distributed Valve business 7 Jul 2020